IL-2 is a key regulator in supporting proliferation and homeostasis of effector T cells but is also crucial for the development of Treg cells, therefore simultaneously leading to increased numbers of Treg cells in melanoma patients [167, 181]. This evidence concerns the gene IL2 and melanoma.